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Abstract At present it is not clear to which extent the Fab 
fragment and the Fc part of an antibody interact in the intact 
imiminoglobulin structure. To determine such potential interac-
tions the unfolding and refolding of an isolated Fab fragment and 
the respective antibody MAK 33 (K/IgGl) are compared. It could 
be shown that the proline independent renaturation kinetics of 
both an unfolding intermediate and the fully denatured form of 
both proteins are identical. Upon denaturation, the loss of 
antigen binding activity occurs with the same rate for both the 
Fab fragment and the intact antibody. However, the complete 
structural unfolding of the Fab part of the antibody is 
significantly slower than that of the isolated Fab fragment. 
These kinetic data suggest that the structure of the Fab fragment 
within the intact antibody is stabilized by interactions, pre-
sumably with the Fc part, missing in the isolated Fab. 
© 1997 Federation of European Biochemical Societies. 
Key words: Ant ibody; Fab fragment; Denaturat ion; 
Renaturat ion; Folding intermediate 
1. Introduction 
Antibodies and their fragments belong to the first genera-
tion of model proteins used for studying protein folding [1]. 
Detailed mechanistic work was performed on single antibody 
domains [2]. An extensive kinetic and structural characteriza-
tion of a C L domain demonstrated the importance of the 
intradomain disulfide bond for the stability and folding of 
the protein [3,4]. This approach was supplemented by the 
analysis of the influence of temperature and dynamics of other 
antibody domains [5-7]. The folding of a light chain could be 
demonstrated to be composed of the individual folding reac-
tion of VL and C L plus an additional reaction, which was 
probably due to an intramolecular interaction between these 
two domains [8]. 
In another set of experiments the interactions between the 
different antibody chains were characterized by measuring the 
dissociation constants of light chain and heavy chain and their 
fragments [9]. Furthermore, the structure of several Fab frag-
ments and one intact antibody were solved by crystallography 
[10,11]. 
Despite this huge amount of information on antibody struc-
ture and folding only little was known about the relation of 
domain folding and domain association reactions during the 
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Abbreviations: Fab, Fab fragment of an antibody consisting of the 
entire light chain and the two N-terminal domains of the heavy chain; 
Fab', proteolytically derived antibody fragment consisting of two Fab 
fragments covalently linked by disulfide bonds within the hinge region; 
MAK 33, intact murine monoclonal antibody (K/IgGl); GdmCl, 
guanidinium chloride 
structure formation of a F a b fragment or the intact antibody 
[12]. 
Recently we analyzed the folding of a Fab fragment in de-
tail (Fig. 1, [13]). We dissected the folding process in prolyl 
isomerization dependent and independent reactions and cor-
related folding and association steps. One of the proposed 
intermediates, Dc, was kinetically and spectroscopically char-
acterized [14]. Here, the analysis was extended to the complete 
antibody M A K 33, showing that the isolated Fab fragment 
and the F a b part within the structural context of the antibody 
behave in some aspects identical, but differed in the sensitivity 
towards denaturation. The data suggest that the F a b fragment 
as part of the antibody is more stable than the isolated Fab . 
2. Materials and methods 
2.1. Materials 
The Fab fragment and the respective antibody MAK 33 (K/IgGl) 
[15,16] and all substances used for the ELISA including the biotiny-
lated human creatine kinase (EC 2.7.3.2) were obtained from Boeh-
ringer Mannheim GmbH. Tris was from ICN, GdmCl A A grade was 
obtained from NIGU. 
2.2. Methods 
2.2.1. Protein concentration. The protein concentrations of Fab 
and MAK 33 were determined spectroscopically using extinction co-
efficients at 280 nm of e= 1.6 and E = 1.5 for a 1 mg/ml solution in a 
1 cm cell [17], respectively. 
2.2.2. Denaturation. Denaturation of Fab and MAK 33 was per-
formed in 0.1 M Tris/HCl, pH 7 at different GdmCl concentrations at 
10°C. The protein concentration was 10-50 mg/ml for fluorescence 
and ELISA analysis. In the case of CD measurements a concentration 
of 1 mg/ml and a light path of 0.1 cm was utilized. The kinetics were 
monitored using a Hitachi F4500 fluorimeter (excitation: 295 nm; 
emission 350 nm; band width both 5 nm; light path 1 cm) in a stirred 
and temperature controlled cell. The CD measurements were per-
formed using a temperature controlled Jasco 720 CD-spectrometer 
at 222 nm. To follow the kinetics of antigen binding activity a quan-
titative ELISA was used [18]. 
2.2.3. Renaturation. Renaturation was achieved by diluting the 
denatured protein 100-fold in 0.1 M Tris/HCl, pH 7 at 10°C. The 
final protein concentration was 10 |ig/ml. 
In the case of renaturation of Dc, Fab and the complete antibody 
were denatured by incubation in 0.1 M Tris/HCl, pH 7, 3.5 M GdmCl 
for 50 s at 10°C [14]. The protein concentration was 1 mg/ml. 
For renaturation starting from the fully denatured state (Uc), native 
protein was incubated in 0.1 M Tris/HCl, pH 7, 6 M GdmCl for 10 s 
at < 10°C. Renaturation was subsequently initiated as described 
above. 
3. Results 
3.1. Unfolding kinetics 
Recently, it was demonstrated that unfolding of a F a b frag-
ment is a biphasic process. First, the antigen binding activity 
is lost and subsequently the whole secondary structure brakes 
down [14]. Thus, unfolding of the intact antibody M A K 33 
should also exhibit these two processes. Fig. 2A shows the 
denaturat ion kinetics of F a b and M A K 33 in the presence 
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n t Fig. 1. Kinetic scheme for the folding of MAK 33 Fab fragment. 
U, denatured protein; I, folding intermediates with non-associated 
chains; D, folding intermediates after intramolecular association; N, 
native protein; c, all prolyl residues in the native conformation; t, 
some prolyl residues in a non-native conformation. The rate con-
stants (min-1) for the rate limitimg steps are indicated (taken from 
[13]). 
of 3 M GdmCl, measured by the loss of antigen binding 
activity, which monitors the conversion of the native state 
N to the intermediate Dc (see Fig. 1). Clearly, the denatura-
tion kinetics of both proteins are identical (k = 0.012 s - 1). 
However, monitoring the denaturation kinetics at 3 M GdmCl 
by far UV CD as a measure of secondary structure reveals 
different rates (kFab = 1.33 X 10" SMAK = 0.2X10" -1) 
for Fab and MAK 33, respectively (Fig. 2B). Using fluores-
cence, both kinetic phases of the denaturation process can be 
observed for Fab and MAK 33 (Fig. 3). It seems that the 
complete structural denaturation of the Fab portion within 
the antibody proceeds 3^1-fold slower than in the isolated 
Fab fragment. Furthermore, the denaturation of the Fab por-
tions and the Fc part seems to be coupled, because the loss of 
secondary structure of the complete antibody is a monophasic 
K 
w 80 
w 
<u 
« 60 
Cu 
m 
<D 4 0 
> 
-i-> 
a 20 
c 
0 
1 1 
r i 
1 1 I 
*°— ° i • i I 
I 
-
-
-
-
8— 
B 
4 6 8 
time (min) 
y y 
10 
9 0 
60 
3 0 
0 
H--:..- ' ' / 
l^^<^.•-■.:" ■ ■' . 
v:.;- ^^i^iS^'.y ■:\: . . ■ : ','..-" .'/.■rt><4> i;. : 
_--y- -V-.'..^v*?v? 
•v... 
■'-v.' . 
- - ^ - v ■ 
. . . . s ; ■ ■ . • • : , . -
■ - v .* • : . ; . .> . . . . . . •.-
. . ■ " ■ • ■ • ' . ' J V \ C ' " - . ' 
i . -. i ■.- / -y y 
0 20 40 120 180 
time (min) 
Fig. 2. Denaturation kinetics of Fab and MAK 33. Native protein 
was diluted into 0.1 M Tris/HCl, pH 7, 3 M GdmCl at 10°C. The 
lines represent fits to single exponential reactions. The rate constants 
are given in Fig. 3. A: ELISA: The protein concentration during 
denaturation was 10 u.g/ml. At different time points aliquots were 
diluted in buffer containing 400 |ig/ml trypsin to stop further rena-
turation and the antigen binding activity was measured by ELISA. 
MAK 33 (•); Fab (o)- B: CD: The protein concentration was 
1 mg/ml. The kinetics were monitored at 222 nm. MAK 33 ( ); 
Fab (- - -). 
process and no further intermediates during denaturation can 
be observed. 
Although the slow phases of denaturation of Fab and 
MAK 33 are different, the GdmCl dependence of these reac-
tions is identical within the experimental error (Fig. 3). A 
molecular interpretation of this phenomenon cannot be given 
at present. 
3.2. Population of Dc during denaturation of MAK 33 
The monophasic denaturation kinetic of MAK 33 measured 
by far UV CD indicates a complete loss of secondary struc-
ture - including that of the Fab portions - in one step. In 
order to confirm that this phase can be attributed to the un-
folding of the Fab part the time dependent distribution of Dc 
during unfolding of the complete antibody was measured. The 
native protein was denatured in 4 M GdmCl. At different time 
points of denaturation aliquots were diluted in strong native 
conditions. After 10 min of refolding the intermediate Dc 
should be converted completely to the native state (see below). 
To prevent further reactivation of other intermediates trypsin 
was added after 10 min of renaturation. The yield of renatu-
ration measured by ELISA represents the concentration of Dc 
at the respective time of denaturation. Fig. 4 shows the de-
crease in the amount of fast refolding species as a function of 
time of denaturation of the complete antibody. This repre-
sents the amount of the intermediate Dc in the case of 
MAK 33. The observed rate for the decrease of the renatura-
tion yield is identical to that observed for denaturation meas-
ured by far UV CD. This result confirms directly that part of 
the amplitude of the monophasic denaturation kinetic meas-
ured by CD is due to the complete unfolding of the Fab 
portion. Therefore, Dc denatures more slowly in MAK 33 
than in Fab. 
3.3. Renaturation kinetics 
The renaturation of the Fab fragment is a complex process 
comprising domain folding, domain association and prolyl 
isomerization [13,19]. In order to simplify the kinetic analysis 
of the reactivation of Fab and MAK 33, the effect of prolyl 
isomerization was circumvented by short unfolding. There-
fore, two kinds of renaturation experiments could be ana-
lyzed, either starting from the intermediate Dc (and the anal-
ogous structure of MAK 33) or from the fully denatured 
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Fig. 3. Guanidinium dependence of denaturation kinetics. The dena-
turation was performed as described in Fig. 1. In the case of fluo-
rescence measurements a protein concentration of 50 ug/ml w a s 
used. The straight lines represent the two denaturation reactions of 
Fab (taken from [14]). The denaturation of MAK 33 was analyzed 
by ELISA ( r ) , CD at 222 nm (■) and tryptophan fluorescence 
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protein with all prolyl residues still in the native isomeric 
form, Uc. Because the rate limiting step of Fab folding is 
the reaction Dc->N [13], the refolding kinetics starting from 
the intermediate Dc and from the completely denatured pro-
tein, Uc, are identical, if analyzed by ELISA. The rate con-
stant was determined to be fcapp =0.3 min
- 1 [14]. 
The comparison of Fab refolding and MAK 33 refolding, 
starting from the fully denatured protein or the intermediate 
structure Dc, analyzed by ELISA or fluorescence, respectively, 
showed no significant difference either (Fig. 5 and data not 
shown). Thus, despite differences in the denaturation behav-
iour of Fab and MAK 33, the renaturation of isolated Fab or 
of Fab within the structural context of the intact antibody was 
identical. 
4. Discussion 
Although detailed knowledge exists about folding and 
stability of isolated antibody domains [2], with these model 
systems the rate limiting and problematic steps in the struc-
ture formation of intact antibodies cannot be analyzed. Only 
little is known about the folding of complex systems com-
posed of antibody domains like Fab fragments [12,20] or in-
tact antibodies [1,21]. In order to get a more detailed insight 
into the problem of antibody folding we recently analyzed the 
renaturation of the oxidized Fab fragment of the monoclonal 
antibody MAK 33 and of a mutant from it, lacking the in-
terchain disulfide bond [13,14]. Based on these results, the 
folding and unfolding of the intact antibody was now ana-
lyzed and compared to the renaturation of the respective Fab 
fragment. For this analysis, an experimental approach was 
chosen allowing to compare only folding or unfolding steps 
which were not determined by prolyl isomerization. 
The kinetic analysis shows that there are no differences 
between both at the late stage of folding and the early unfold-
ing reactions (Dc ^ N) of the complete antibody and the Fab 
fragment, respectively. Therefore, the formation of native 
structure including tight packing of the side chains in the 
contact sites between domains and the antigen binding site 
seems to occur in a very similar way in both proteins. How-
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Fig. 4. Time dependent distribution of Dc during MAK 33 denatu-
ration. MAK 33 was denatured in 4 M GdmCl at 1 mg/ml, 10°C. 
At different time points aliquots were withdrawn and 100-fold di-
luted into 0.1 M Tris/HCl, pH 7, 10°C to allow renaturation of the 
denatured protein. After 10 min incubation renaturation was 
blocked by adding 400 ug/ml trypsin and the amount of native anti-
body was determined by ELISA (o). The first value after 30 s of 
denaturation was set to 100%. The observed rate, representing the 
kinetics of Dc denaturation (see text), was k = 0.003 s_1. For com-
parison, the denaturation kinetic of the intermediate Dc of the iso-
lated Fab fragment is given (dotted line, taken from [14]). 
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Fig. 5. Renaturation kinetics of the complete antibody. The partially 
denatured (Dc, o) and completely denatured (Uc, • ) protein was re-
folded by a 100-fold dilution into 0.1 M Tris/HCl, pH 7 at 10°C. 
The final protein concentration was 10 ug/ml. Renaturation was 
measured by ELISA. Fits of the data yield apparent rate constants 
between fc = 0.3 and 0.43 min-1 for all refolding reactions. 
ever, the Fab fragments isolated or within the structural con-
text of the antibody are clearly not identical. The complete 
denaturation of the Fab portion is significant slower within 
the intact antibody, indicating a higher energy barrier for 
unfolding compared to that of the isolated Fab fragment. 
This could be achieved by a higher structural stability of the 
Fab portion in the complete antibody as compared to the 
isolated Fab fragment. 
There is only very limited information on the structure of 
intact antibodies. The crystal structure of an IgG2a antibody 
[11] shows two Fab fragments in different angles to the Fc 
part, indicating the flexibility of the structure. The authors 
reasonably proposed that this structure might be only one 
of many possible conformations, probably selected by its abil-
ity to crystallize. Analysis in solution using H/D exchange 
experiments showed different kinetics of H/D exchange reac-
tions for Fab and Fab' on one hand and the intact antibody 
(IgGl) on the other hand [22]. This indicates interactions 
between Fab and Fc in the complete antibody. This interpre-
tation together with the kinetic data presented here suggests 
an energetic scheme given in Fig. 6. Although folding and 
unfolding kinetics ( N ^ D c ) are identical for Fab and MAK 
33, the respective structures N an Dc are more stable in the 
case of the complete antibody. The difference in stability be-
comes significant and apparent upon further denaturation of 
Dc. The intermediate Dc is characterized by native like sec-
ondary structural content, but clearly different tertiary/quater-
nary contacts than the native state [14]. At least one of the 
variable domains is non-native in this intermediate, because 
Dc has lost its ability to react in the ELISA system. Probably, 
also the interaction between the constant domains differs from 
the tight packing of the native contacts. This is suggested by 
the fact that the C-terminal interchain disulfide bond between 
light chain and Fd fragment is essential for population of this 
intermediate [14], which would not be the case if the intra-
molecular association of the two chains within Dc would be 
mediated by the stable interaction of native constant domains. 
Nevertheless, the kinetic analysis of the complete antibody 
showed a stabilization of Dc compared to the isolated Fab 
fragment, presumably by the interaction with the Fc part. In 
the native context such an interaction was observed between 
C H I and CH2 [22], suggesting that even in the intermediate, 
Dc, part of the surface of CH 1 possesses native like features 
allowing this interaction to occur. 
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Fig. 6. Possible energetic scheme of Fab and MAK 33 folding. Fab 
( ) and MAK 33 (dotted line) differ in their stability of the na-
tive structure N and the intermediate Dc. The activation energy of 
the reaction Dc->Uc is different. In this scheme, the reaction 
Uc->Dc is assumed to be identical for Fab and MAK 33. 
The structural unfolding of the complete antibody is a 
highly cooperative process. The antibody consists of 12 struc-
tural domains. However, the denaturation kinetics measured 
by far UV CD only reveals a single denaturation reaction. 
Thus, all domains unfold simultaneously. Also Fc seems to 
be stabilized because the isolated domain CH3 denatures much 
faster in the isolated form than in the intact antibody (unpub-
lished data). 
It should be noted that Fig. 6 represents the energetics 
under native conditions. Thus, the denaturation kinetics of 
MAK 33 must be slower than that of Fab at 0 M GdmCl. 
Denaturation at 0 M GdmCl cannot be measured directly. 
However, measuring the kinetics of unfolding at different 
GdmCl concentrations allows to extrapolate to 0 M GdmCl. 
As shown in Fig. 3 the slopes of the rate of denaturation 
versus GdmCl concentration are identical for Fab and 
MAK 33, respectively. Therefore, at conditions relevant for 
the energetic scheme (e.g. at 0 M GdmCl, Fig. 6) denaturation 
of the structured intermediate of MAK 33 is slower than that 
of Fab. 
This interpretation assumes that during folding interaction 
between the Fab portion and Fc of the complete antibody 
occurs for the first time at the level of Dc. In principle, it is 
also possible that this interaction changes the transition state 
between Dc and less structured conformations (TS1 in Fig. 6). 
Whether this transition state is identical for Fab and MAK 33 
or differs energetically cannot unambiguously be concluded 
from the data. 
Taken together, it was shown that Fab fragments, isolated 
or within the structural context of an antibody act in some 
aspects clearly different. The structure of Dc within the intact 
antibody seems to be stabilized by the additional interactions 
to the Fc part, resulting in slower denaturation kinetics com-
pared to the isolated Fab. An analysis of the protein stability 
of Fab and MAK 33 cannot be given because unfolding of 
both proteins is not completely reversible. However, the ki-
netic data together with the dynamic information on antibody 
architecture [22] suggest that the Fab portion is more stable 
within the intact antibody than in the isolated form. 
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